Volume 9 Issue 10, Oct 2024

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 9 Issue 10, Oct 2024:
Research Highlight
Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition
Marc A. Weniger &Ralf Küppers  ORCID: orcid.org/0000-0002-6691-7191